Primary pure large-cell neuroendocrine carcinoma of the ovary

Pavel Dundr(Charles University), David Cibula(Charles University), D. Fischerová(Charles University), C Povýšil(Unknown)
Pathology - Research and Practice
February 1, 2008
10.1016/j.prp.2007.09.004
Cited by 32

Related Papers

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
|Annals of Oncology|2019|1.2k
Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study
|BMJ|2014|500
Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group
|BMJ|2010|473
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group
|American Journal of Obstetrics and Gynecology|2016|329